Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHSE: 688192)
Health Care · Biotechnology · CN
CN¥59.95
+3.34% today · -10.1% 1Y
Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHSE: 688192) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.16B.
Over the last twelve months the share price has lost 10.1%, trading between 35.73 and 71.26.
Tweenvest scores Dizal (Jiangsu) Pharmaceutical Co., Ltd. across four factors: quality 37/100, value 71/100. Its strongest factor is value.
688192 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.16B
- Revenue (TTM)
- $142.63M
- P/E
- —
- EPS
- -1.29
- Dividend yield
- —
- Beta (5Y)
- -0.01
- 52-week high
- CN¥71.26
- 52-week low
- CN¥35.73
- Avg volume (3M)
- —
- Shares outstanding
- 465.17M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Dianthus Therapeutics, Inc.NasdaqCM: DNTH | $4.61B | $82.17 | -0.24% |
| Lin BioScience, Inc.TPEX: 6696 | $4.54B | NT$175.00 | -3.58% |
| Shanghai Junshi Biosciences Co., Ltd.SEHK: 1877 | $4.45B | HK$17.65 | -2.32% |
| Imeik Technology Development Co.,Ltd.SZSE: 300896 | $4.28B | CN¥95.03 | -0.16% |
| Suzhou Zelgen Biopharmaceuticals Co., Ltd.SHSE: 688266 | $4.12B | CN¥104.25 | -5.23% |
| Tango Therapeutics, Inc.NasdaqGM: TNGX | $4.01B | $24.00 | +0.80% |
| Relay Therapeutics, Inc.NasdaqGM: RLAY | $3.92B | $17.92 | +0.22% |
| Telix Pharmaceuticals LimitedASX: TLX | $3.76B | AU$15.85 | -0.13% |
Figures last refreshed Oct 11, 2026.